GlassScriptPhysician profile
Jennifer Madeo
NPI 1750678488
$1,170.47
in general payments reported to CMS, 2019-2025
19 companies · $62.17 in 2025
The $62.17 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.10 · 2020: $354 · 2021: $167 · 2022: $62.82 · 2023: $339 · 2024: $173 · 2025: $62.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $366.09 | 2020-2025 | |
| Smith+Nephew, INC. | $121.60 | 2023 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Iodosorb Ointment 40g USA, Acticoat 4" X 4" |
| Viiv Healthcare Company | $115.60 | 2020-2023 | Dovato |
| Paratek Pharmaceuticals, INC. | $104.59 | 2020-2021 | |
| Gilead Sciences, INC. | $76.77 | 2020-2021 | |
| Melinta Therapeutics, LLC | $63.15 | 2020 | |
| Organogenesis INC. | $53.56 | 2024 | |
| Amgen INC. | $49.81 | 2024-2025 | Tavneos |
| Merck Sharp & Dohme LLC | $48.58 | 2020-2021 | |
| Boston Scientific Corporation | $24.14 | 2023 | |
| Allergan, INC. | $23.58 | 2020 | |
| Novo Nordisk INC | $23.14 | 2019-2020 | |
| Insmed, INC. | $21.35 | 2020 | |
| Hologic Sales and Service, LLC | $15.84 | 2025 | Aptima |
| Janssen Biotech, INC. | $14.97 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $14.55 | 2021 | |
| Theratechnologies INC. | $13.70 | 2023 | Egrifta, Trogarzo |
| Aurinia Pharma U.S., INC. | $12.12 | 2022 | |
| Reprise Biomedical, INC. | $7.33 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Madeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.